Overview

International Vaccine Institute, IVI, was established in 1997 as a multilateral research institute which develops vaccines in order to reduce the burden of poverty-related disease. IVI offers technical assistance to vaccine producers and regulators in low- and lower-middle-income countries, and maintains an international network of collaborating research institutions. Sida has supported IVI since 2002, and provides non-earmarked program support to IVI's strategy implementation.

Involved parties

:
-
:
IVI/International Vaccine Institute
:
IVI/International Vaccine Institute
:
  • B021 - Core contributions to multilateral institutions

Strategies governing the contribution

  1. Research cooperation 2022-202819,000,000 SEK 100% of total

Geographical allocation of the contribution

No countries have been assigned to this contribution.

Development areas for the contribution

No development areas have been assigned to this contribution.

Duration of the contribution

July 30, 2024
September 30, 2029
Ongoing

Committed and disbursed amount

Agreed amount SEK 25,000,000

Paid amount SEK 19,000,000

Paid per year (net value)

  • 2024: SEK 16,000,000
  • 2026: SEK 3,000,000

Sustainable Development Goals

The contributions contribution to the UN's global sustainability goals.

  • Global Goals, goal 17: Partnerships for the goals
  • Global Goals, goal 3: Good health and well-being
  • Global Goals, goal 9: Industry, innovation and infrastructure